Limited T‐Cell Receptor V Gene Usage in Inclusion Body Myositis
暂无分享,去创建一个
A. Oldfors | A. Tarkowski | C. Lindberg | A. Moslemi | I. Fyhr | I.‐M. FYHR
[1] A. Tarkowski,et al. Local T‐Cell Proliferation and Differentiation in Inflammatory Myopathies , 1995, Scandinavian journal of immunology.
[2] A. Tarkowski,et al. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies , 1994, European journal of immunology.
[3] M. Dalakas,et al. The αβ T-Cell Receptor Repertoire in Inclusion Body Myositis: Diverse Patterns of Gene Expression by Muscle-infiltrating Lymphocytes , 1994 .
[4] R. Holmdahl,et al. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin‐1‐producing staphylococci , 1994, European journal of immunology.
[5] A. Oldfors,et al. Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases , 1994, Acta Neurologica Scandinavica.
[6] F. Breedveld,et al. T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. , 1993, Human immunology.
[7] L. Steinman,et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. , 1993, The Journal of clinical investigation.
[8] M. Joffe,et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. , 1993, The American journal of medicine.
[9] A. Begovich,et al. Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.
[10] L. Steinman,et al. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. , 1992, BioTechniques.
[11] D. Carlo,et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Dalakas. Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.
[13] R. Hohlfeld,et al. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies , 1991, Annals of neurology.
[14] L. Hood,et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.
[15] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[16] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells , 1988, Annals of neurology.
[17] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[18] R. Hohlfeld,et al. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. , 1991, The New England journal of medicine.